|
0
|
|
In vitro PK/PD modeling and simulation to accurately assess the antimicrobial activity of tigecycline against Mycobacterium abscessus.
(journals.asm.org)
|
Park H
…
Meibohm B
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#modeling
#infection
#amr
#pharmacodynamics
#susceptibility
|
|
0
|
|
Pharmacokinetics/pharmacodynamics of ceftazidime-avibactam in critically ill adult patients receiving continuous renal replacement therapy.
(journals.asm.org)
|
Li C
…
Ge Y
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#pharmacokinetics
#dosing
#amr
#pharmacodynamics
#sepsis
|
|
0
|
|
US Food and Drug Administration, Centers for Disease Control and Prevention, and National Institutes of Health Co-Sponsored Public Workshop Summary-Development Considerations of Antimicrobial Drugs for the Treatment of Gonorrhea.
(academic.oup.com)
|
Hiruy H
…
Farley JJ
Clinical Infectious Diseases
2026-02-04
|
#infection
#amr
#pharmacodynamics
#drug development
|
|
0
|
|
A modeling-based framework to evaluate forgiveness of tuberculosis treatment in a BALB/c relapsing mouse model.
(journals.asm.org)
|
Sordello S
…
Upton AM
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#modeling
#amr
#pharmacodynamics
#tb
|
|
0
|
|
A mechanism-based pharmacokinetic/pharmacodynamic analysis of polymyxin B-based combination therapy against carbapenem-resistant Klebsiella pneumoniae isolates with diverse phenotypic and genotypic resistance mechanisms.
(journals.asm.org)
|
Mahadevan R
…
Rao GG
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#modeling
#infection
#amr
#pharmacodynamics
|
|
0
|
|
Preclinical pharmacokinetics/pharmacodynamics studies defining the role of ethambutol in Mycobacterium kansasii lung disease.
(journals.asm.org)
|
Gumbo T
…
Srivastava S
Antimicrobial Agents and Chemotherapy
2026-02-04
|
#pharmacokinetics
#modeling
#amr
#pharmacodynamics
#tb
|